Avocats – United States

David Lender

Co-Chair of Weil’s global Litigation Department

Weil, Gotshal & Manges LLP

David Lenzi

David Lenzi is a corporate partner in Kirkland’s New York office, focusing on the representation of private investment fund sponsors. He has represented a wide range of clients on the development, formation and marketing of funds, as well as providing advice on ongoing transactional and regulatory matters. He has significant experience representing sponsors on internal governance and ownership arrangements and has advised on a number of private and public asset management M&A transactions.

Kirkland & Ellis LLP

David Lesser

Partner

King & Spalding

David Levine

Partner David Levine focuses his practice on all aspects of international trade and related regulatory matters. He counsels clients on import relief, customs, export controls, trade sanctions, anti-boycott and anticorruption laws, and related trade laws and procedures. David represents clients in antidumping and countervailing duty cases and related federal appellate litigation, trade controls and customs audits and enforcement proceedings, trade-related legislative and rulemaking proceedings, and trade negotiations. For further details of David's biography, please view McDermott website: https://www.mwe.com/en/team/l/levine-david-j

McDermott Will & Schulte

David Levine

Principal

Groom Law Group, Chartered

David Lewis

Partner; Managing Partner, Phoenix Office

DLA Piper LLP (US)

David Lieberman

Member of the Firm’s Corporate Department and Managing Partner of the Firm’s Houston office. Representative clients include Blackstone, EQT Infrastructure, Digital Bridge, Morgan Stanley Infrastructure Partners, Stonepeak Infrastructure Partners, Global Infrastructure Partners and NextEra Energy.

Simpson Thacher & Bartlett LLP

David Lindsey

Founding Partner

Chaffetz Lindsey LLP

David Lisner

Partner

Cohen & Gresser LLP

David Livshiz

David Livshiz represents clients in complex commercial disputes, criminal and civil fraud actions, and bankruptcy litigation. He also works with companies and individuals in criminal and civil investigations conducted by the US Department of Justice, the Attorneys’ Office, the Securities and Exchange Commission and various other regulatory agencies.

Freshfields

David Lopez

David Lopez represents a broad range of corporate clients including in the retail, industrial, financial, healthcare, insurance and technology sectors. His broad corporate advisory practice including governance, SEC disclosure and compliance, corporate finance transactions and structuring, securities law, buybacks and insider trading advice. David represents issuers and investment banks in capital markets transactions involving initial public offerings, public and private debt, convertible, investment grade and high yield debt, equity financings, structured securities and equity derivatives. He has the leading practice in liability management, including issuer tender offers, public and private exchanges offers related to corporate restructurings, acquisitions, and consent solicitations. He also has a substantial practice in digital assets, representing digital assets custodians, payment companies, exchanges, and corporates both in the creation of digital assets and with related compliance issues.

Cleary Gottlieb Steen & Hamilton

David Lowman

Special Counsel

Hunton Andrews Kurth LLP

David Luce

Please see https://www.willkie.com/professionals/l/luce%20david

Willkie Farr & Gallagher LLP

David Lynn

Partner

Goodwin

David M. Fox

Partner

Hogan Lovells US LLP

David M. Orta

Quinn Emanuel Urquhart & Sullivan, LLP

David M. Zornow

Of Counsel

Skadden, Arps, Slate, Meagher & Flom LLP

David MacDonald

David MacDonald focuses on intellectual property, pharmaceutical and technology transactions, including joint ventures, consortiums and strategic alliances. He regularly advises pharmaceutical and biotechnology clients on transactional matters, including licensing, marketing and co-promotion, supply and distribution, and other collaboration arrangements. He advises global technology companies on patent strategies, patent and software licensing (including settlement of patent litigation), and monetization (assertion, securitizations, trusts and investment funds). David also advises clients on the intellectual property issues that arise in mergers, acquisitions, divestitures, recapitalizations and bankruptcies. Since 2010, David has been included in Intellectual Asset Management magazine’s list of the world’s top 250 patent and technology licensing lawyers for his “cutting-edge expertise on how patent law issues complicate licensing deals” and his “impressive profile in IT outsourcing.” David has also been included in the IAM Patent 1000 since 2012, which describes him as “one of the pharmaceutical industry’s go-to deal brokers” and says he “manifests a rare faculty for facilitating complex collaborations and transactions between life sciences entities.” David was also highlighted in The Legal 500 United States 2012, 2015, 2017, 2018, 2020, 2021, 2022, 2023 and 2024 guides to leading U.S. law firms for business. David is the former Chair of the Transactions Involving IP Rights Committee of the ABA and named one of Managing Intellectual Property magazine’s “IP Stars,” 2020–2025.

Kirkland & Ellis LLP

David Mahaffey

David is the managing partner of the Washington, D.C. office. Prior to joining Sullivan & Worcester, David was Special Counsel in the Washington, D.C. office of Gibson, Dunn & Crutcher. He previously served as Assistant General Counsel for Legislation and Investment Company and Adviser Regulation at the Securities and Exchange Commission and as Counsel to SEC Commissioner Aulana Peters. David's client work includes: Representing mutual funds, exchange-traded funds, closed-end funds, and business development companies and their independent trustees in connection with fund organization, public offerings and operations Representing investment advisers and investment company boards in mergers and acquisitions Representing investment advisers and broker-dealers with respect to regulatory matters and law enforcement investigations arising under the federal securities laws Advising public companies concerning their status under the Investment Company Act of 1940

Sullivan & Worcester LLP

David Maiorana

Partner

Jones Day

David Mallen

Partner and Co-Chair, Advertising Disputes; Chair, Retail & Consumer Brands

Loeb & Loeb LLP

David Malliband

David Malliband currently serves as managing partner of Baker McKenzie's Chicago Office and was formerly chair of its Corporate & Securities Practice Group in Chicago. He has over 25 years' experience advising multinational corporations on cross-border transactions. David has practiced in each of Baker McKenzie's Sydney, London and Chicago Offices, and has closed transactions for companies around the world in a wide variety of industries. He has been recognized as a "Star Lawyer" by Acritas, "Stand-out Lawyer" by Thomson Reuters, and for delivering superior client service in The BTI Client Service "All-Star Team" for Corporate Transactions report, based on interviews with Fortune 500 companies.

Baker McKenzie

David Manko

David is a partner in Proskauer's Corporate Department and Chair of the Health Care Group. With more than 30 years of experience, David has represented virtually every type of stakeholder in the health care services sector. David leverages his industry expertise to provide practical, creative and actionable advice to healthcare clients in connection with complex business transactions and regulatory matters. Across his career, clients have included investors, lenders, management companies, payers, hospital organizations and health systems, medical practices, provider networks, medical technology companies, digital health companies, nonprofit entities and public benefit corporations. David has particular expertise representing clients involving large, national provider networks and risk bearing entities, including in connection with regulatory structuring issues, fraud and abuse and value-based contracting. In the community, David is dedicated to expanding access to primary care services for underserved populations. For almost 10 years, he has been an active member of the Board of Directors of Primary Care Development Corporation (“PCDC”). PCDC is a nonprofit Community Development Financial Institution dedicated to providing low-cost debt financing to not-for-profit organizations to expand and improve primary care in underserved communities.

Proskauer Rose LLP

David Mann

David Mann’s practice is focused primarily on upstream and midstream energy transactions. He has represented clients in connection with numerous asset acquisitions and divestitures (including sale processes under Section 363 of the Bankruptcy Code) as well as joint ventures, farmouts, and similar transactions for developing oil and gas assets. He also advises clients on day-to-day legal issues that arise in the upstream and midstream energy industry and has experience negotiating joint operating agreements, oil and gas leases, easements, surface use agreements, drilling contracts, master service agreements, confidentiality agreements, gathering, processing and disposal agreements, and other energy-related documentation. Prior to law school, David was a licensed Certified Public Accountant in Texas working as a senior assurance associate with a large public accounting firm.

Porter Hedges LLP